Philip Morris to Launch IQOS ILUMA NEON PURPLE in Spain

Jun.11.2024
Philip Morris to Launch IQOS ILUMA NEON PURPLE in Spain
Philip Morris International (PMI) to launch limited edition IQOS ILUMA NEON PURPLE in Spanish cities with innovative digital campaign.

According to a recent report by Ipmark, Philip Morris International (PMI) will launch a limited edition new product called IQOS ILUMA NEON PURPLE in several cities in Spain this summer.


The company plans to conduct a summer digital advertising campaign (Fake Out Of Home) in the cities of Madrid, Barcelona, and Valencia. They will decorate a limited edition blimp in neon colors and have it fly in the skies of Madrid, Barcelona, and Valencia. The blimp will also interact with the cities and use neon lights to illuminate three stores of the brand located in those three locations during its flight.


Alejandro Flores, marketing manager for IQOS in the Spanish market, stated that...


IQOS has changed the game by offering a product that heats tobacco instead of burning it, creating a better alternative to smoking. Innovation, disruption, and finding better ways of doing things have always been the brand's DNA. These values are not only reflected in the product itself but also in their communication strategies, which is why they are launching the "Fake Out Of Home" campaign to showcase their latest product: IQOS ILUMA NEON PURPLE.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai
ITGA 与 2Firsts 签署战略合作备忘录,共同支持全球烟草种植者
ITGA 与 2Firsts 签署战略合作备忘录,共同支持全球烟草种植者
ITGA Annual General Meeting 2025 held in Germany alongside InterTabac/InterSupply 2025 showcases global tobacco supply chain opportunities.
Sep.23 by 2FIRSTS.ai
Interview with Germany’s BfTG: 40% of Market Lost to Illicit Trade, Industry Calls for Smarter Regulation
Interview with Germany’s BfTG: 40% of Market Lost to Illicit Trade, Industry Calls for Smarter Regulation
At the InterTabac trade show in Dortmund, Philip Drögemüller, Managing Director of Germany’s Smoke-Free Alliance (BfTG), spoke with 2Firsts. He said Germany’s vaping market still has substantial potential, but the industry faces policy uncertainty and compliance pressure. The association urges companies to operate compliantly and to shift from disposable products to rechargeable systems as early as possible to prepare for the structural adjustments brought by the EU battery rules in 2027.
Sep.20 by 2FIRSTS.ai
Spain's Proposed E-cigarette and Nicotine Pouch Restrictions Spark EU Debate
Spain's Proposed E-cigarette and Nicotine Pouch Restrictions Spark EU Debate
Lead: Spain's proposed e-cigarette and nicotine pouch restrictions face strong opposition from seven EU countries and the European Commission.
Aug.21 by 2FIRSTS.ai
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
In a 2Firsts exclusive, ARAC’s Dr. Zdinak explains FDA’s blu rejection stems from weak behavioral science data and urges companies to strengthen Module 6 studies immediately.
Aug.20
Malaysia Considers Implementing Stricter Measures on E-Cigarettes Amid Rising Usage, Following Singapore's Model
Malaysia Considers Implementing Stricter Measures on E-Cigarettes Amid Rising Usage, Following Singapore's Model
Malaysian public health experts and organizations are calling on the government to follow Singapore's lead in treating e-cigarettes as a drug issue and implementing stricter penalties to curb the surging use among teenagers. An official from the Penang Consumers' Association pointed out that many e-cigarettes contain the addictive substance etomidate, the misuse of which could endanger health. He criticized young people, especially females, for being nonchalant about the dangers of e-cigarettes.
Aug.21 by 2FIRSTS.ai